PRMT1 drives cervical cancer progression by orchestrating cell growth, migration, and angiogenesis.
Liu WY, Huang HW, Ma JN, Xue L
Cancer Biology
Cancer research rarely crosses into the garden, but the molecular signaling pathways studied here — cell growth, apoptosis, and angiogenesis — are the same ones plant biologists probe when studying how tumors form in crown gall disease caused by Agrobacterium in roses and fruit trees.
Scientists discovered that a specific protein is unusually active in cervical cancer cells and helps them multiply, move around, and even recruit new blood vessels to feed the tumor. When they switched off this protein using gene-editing tools, cancer cells grew much more slowly and were less able to spread. This makes the protein a promising target for future cancer treatments.
Key Findings
PRMT1 was elevated in cervical cancer tissue and correlated with higher tumor grade and lymph node metastasis, though not with overall survival
Knocking out PRMT1 in HeLa cells inhibited proliferation, colony formation, and migration while triggering cell death and arresting cells in the S-phase of division
In live animal (xenograft) models, PRMT1 knockout significantly reduced tumor growth and lowered markers of cell division (Ki-67) and blood vessel formation (CD31)
chevron_right Technical Summary
Researchers found that a protein called PRMT1 helps cervical cancer grow, spread, and form new blood vessels. Removing it in lab and animal models slowed tumor growth significantly.
Abstract Preview
PRMT1 is an important regulator implicated in multiple malignancies, yet its role in cervical cancer remains unclear. In this study, we investigated the functional significance of PRMT1 in cervical...
open_in_new Read full abstractAbstract copyright held by the original publisher.
Was this useful?
Want to tell us more? (optional)
Thanks for the note!
Something went wrong — please try again.
Too many submissions. Try again in an hour.
Chloroplast Genome Editing Eliminates Gluten Immunogenicity in Triticum aestivum
It could mean that people with celiac disease — roughly 1 in 100 worldwide — may one day safely eat bread made from real wheat, without sacrificing the taste...